Belvedere Trading’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Belvedere Trading’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,610	Closed	-$241K	–	1648
2022 Q4	$241K	Sell	19,610 -7,608	-28%	-$181K	﹤0.01%	283
2022 Q3	$890K	Buy	+27,218	New	+$769K	0.03%	45

Belvedere Trading's CINC Position: Q1 2023 in Review

Belvedere Trading sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 19,610 shares — an estimated $241K sold.

Belvedere Trading first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $890K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Belvedere Trading reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Belvedere Trading sold 19,610 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $241K.
Belvedere Trading first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Belvedere Trading's CinCor Pharma, Inc. Common Stock position peaked at $890K in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.